Jason Pope, MD
Pain Medicine · Santa Rosa, CANPI 1215078647
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,355,263 of the $2,051,684 with a category attached, or 66.1%. 29 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 36.2% of the total. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,994 payments — averaging $1028.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$743K
- Abbott$692K
- Aurora Spine, Inc.$238K
- Flowonix Medical Incorporated$145K
- Vertos Medical, Inc.$90K
- Biotronik NRO, Inc.$56K
- plus $86K from 23 others
Across 266 payments — averaging $2983.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Painteq LLC$327K
- Saluda Medical Americas, Inc.$243K
- Abbott$93K
- MML US, Inc.$62K
- SPR Therapeutics, Inc$40K
- Vertos Medical, Inc.$15K
- plus $14K from 3 others
Across 10 payments — averaging $807.00 each. An ownership or investment interest held by the physician or an immediate family member.
- SPR Therapeutics, Inc$8K
- Saluda Medical Americas, Inc.$0
- Anesthetic Gas Reclamation, Inc$0
What the payments were for
- Royalty or licence$101,4275%
- Consulting fees$1,355,26366%
- Speaking & faculty fees$398,16919%
- Travel & lodging$132,1626%
- Food & beverage$52,5313%
- Ownership interest$12,1331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 390 | $743,002 |
| Abbott | 1,214 | $691,792 |
| Aurora Spine, Inc. | 41 | $238,428 |
| Flowonix Medical Incorporated | 4 | $145,251 |
| Vertos Medical, Inc. | 79 | $90,459 |
| Biotronik NRO, Inc. | 85 | $56,298 |
| Vertiflex, Inc. | 28 | $34,882 |
| Medtronic(2 entities) | 28 | $14,071 |
| MML US, Inc. | 28 | $13,858 |
| Biotronik Inc. | 10 | $12,181 |
| Insightec,inc | 1 | $3,000 |
| Tersera Therapeutics LLC | 3 | $2,121 |
| Painteq LLC | 32 | $1,903 |
| SPR Therapeutics, Inc | 7 | $1,008 |
| Genentech, Inc. | 1 | $655 |
| Spinal Simplicity, LLC | 4 | $417 |
| Nevro Corp. | 5 | $389 |
| Si-bone, Inc. | 4 | $367 |
| Boston Scientific | 9 | $269 |
| Bioventus LLC | 2 | $234 |
| Relievant Medsystems, Inc. | 5 | $209 |
| Stryker | 3 | $208 |
| Nalu Medical, Inc. | 3 | $187 |
| Curonix LLC | 2 | $170 |
| Medline Industries LP | 2 | $161 |
| Averitas Pharma Inc. | 1 | $58 |
| Globus Medical | 1 | $54 |
| AbbVie | 1 | $29 |
| Trevena, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$454,977
- Evoke SCS$282,566
- PROCLAIM$249,687
- ZIP$238,368
- Prometra II$145,251
- Neuromodulation Dspsbls and Accs$107,610
- Proclaim Family of SCS IPGs$104,400
- Axium INS DRG IPG$97,731
- mild Device Kit$89,639
- IonicRF Generator$53,042
- Prospera$47,362
- Superion ISS$34,257
- Proclaim DRG IPG$25,218
- Proclaim IPG$20,261
- ReActiv8$13,469
- INTELLIS$10,849
- Infinity DBS Pulse Generators$10,238
- BIOTRONIK$7,113
- Proclaim Plus SCS with FlexBurst360$2,560
- SYNCHROMEDII$2,250
How this compares
$2,051,684 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 416 | $10,852 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 218 | $5,872 |
| Lidocaine | 59 | $5,360 |
| Gabapentin | 313 | $4,155 |
| OxycontinOxycodone Hcl | 13 | $3,030 |
| Oxycodone Hcl | 130 | $2,594 |
| Pregabalin | 139 | $2,448 |
| Celecoxib | 72 | $1,776 |
| Morphine Sulfate ErMorphine Sulfate | 56 | $1,634 |
| Naloxone Hcl | 28 | $1,539 |
| Cyclobenzaprine Hcl | 66 | $853 |
| Cephalexin | 93 | $531 |
| Tizanidine Hcl | 62 | $517 |
| Morphine Sulfate | 19 | $490 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $450 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Santa Rosa
- Michael YangSanta Rosa$90K
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.